Title: Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer disease Mehta KM, Yin M, Resendez C, Yaffe K Ref: Neurology, 65:159, 2005 : PubMed
Acetylcholinesterase inhibitors (AChIs) have been demonstrated to improve Alzheimer disease symptoms. Whether the use of AChIs varies by ethnicity is unknown. More than 2500 ethnically diverse patients (6% African American, 14% Latino, and 7% Asian patients) from the Alzheimer's Disease Research Centers in California were studied. Compared with white patients with AD, minority patients had 40% lower odds of AChI use (odds ratio 0.6, 95% confidence interval: 0.5 to 0.7).
        
Related information
Citations formats
Mehta KM, Yin M, Resendez C, Yaffe K (2005) Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer disease Neurology65: 159-62
Mehta KM, Yin M, Resendez C, Yaffe K (2005) Neurology65: 159-62